We've found
1,179
archived clinical trials in
Anxiety
We've found
1,179
archived clinical trials in
Anxiety
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Updated: 9/23/2015
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Updated: 9/26/2015
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials
Psychotherapy for Depressed or Anxious Adolescents With Cancer
Updated: 10/5/2015
Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer
Status: Enrolling
Updated: 10/5/2015
Psychotherapy for Depressed or Anxious Adolescents With Cancer
Updated: 10/5/2015
Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Updated: 10/6/2015
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated: 10/6/2015
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Updated: 10/6/2015
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Updated: 10/8/2015
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated: 10/8/2015
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Updated: 10/8/2015
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Updated: 10/13/2015
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Medical Use of Song In Critical Care (MUSIC)
Updated: 10/20/2015
Medical Use of Song In Critical Care (MUSIC)
Status: Enrolling
Updated: 10/20/2015
Medical Use of Song In Critical Care (MUSIC)
Updated: 10/20/2015
Medical Use of Song In Critical Care (MUSIC)
Status: Enrolling
Updated: 10/20/2015
Click here to add this to my saved trials
Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder
Updated: 11/3/2015
Cognitive and Interpersonal Therapies for Generalized Anxiety
Status: Enrolling
Updated: 11/3/2015
Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder
Updated: 11/3/2015
Cognitive and Interpersonal Therapies for Generalized Anxiety
Status: Enrolling
Updated: 11/3/2015
Click here to add this to my saved trials
Self-Defense Training in Women With Trauma
Updated: 11/18/2015
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated: 11/18/2015
Self-Defense Training in Women With Trauma
Updated: 11/18/2015
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated: 11/18/2015
Click here to add this to my saved trials
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Updated: 11/24/2015
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Status: Enrolling
Updated: 11/24/2015
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Updated: 11/24/2015
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Status: Enrolling
Updated: 11/24/2015
Click here to add this to my saved trials
Pediatric Laser Acupuncture and Renal Biopsy
Updated: 11/30/2015
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
Pediatric Laser Acupuncture and Renal Biopsy
Updated: 11/30/2015
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Pediatric Laser Acupuncture and Renal Biopsy
Updated: 11/30/2015
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
Pediatric Laser Acupuncture and Renal Biopsy
Updated: 11/30/2015
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Updated: 11/30/2015
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Status: Enrolling
Updated: 11/30/2015
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Updated: 11/30/2015
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Lavender Aromatherapy for Anxiety During Urodynamics
Updated: 11/30/2015
The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure
Status: Enrolling
Updated: 11/30/2015
Lavender Aromatherapy for Anxiety During Urodynamics
Updated: 11/30/2015
The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Updated: 11/30/2015
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Status: Enrolling
Updated: 11/30/2015
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Updated: 11/30/2015
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Updated: 12/2/2015
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/2/2015
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Updated: 12/2/2015
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Brief Behavioral Treatment for Anxiety in Young Children
Updated: 12/2/2015
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated: 12/2/2015
Brief Behavioral Treatment for Anxiety in Young Children
Updated: 12/2/2015
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Updated: 12/2/2015
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated: 12/2/2015
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Updated: 12/2/2015
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
Updated: 12/4/2015
A Retrospective Analysis of Outcomes in Outpatients With Major Depressive Disorder (MDD) in a Staff Model HMO: Pharmacogenetic Algorithm for Psychotropic Pharmacotherapeutic Applications
Status: Enrolling
Updated: 12/4/2015
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
Updated: 12/4/2015
A Retrospective Analysis of Outcomes in Outpatients With Major Depressive Disorder (MDD) in a Staff Model HMO: Pharmacogenetic Algorithm for Psychotropic Pharmacotherapeutic Applications
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials